Advanced Aromatase Inhibition Research
Anastrozole is a non-steroidal aromatase inhibitor developed for sophisticated laboratory investigations into estrogen biosynthesis mechanisms. As a competitive inhibitor of the aromatase enzyme (CYP19A1), this compound serves as an essential reference standard for researchers examining hormonal pathway modulation at Stroid UK Shop. The Hemi Pharma formulation provides research-grade material suitable for comprehensive biochemical analyses and cellular studies investigating estrogen-dependent processes.
Research scientists studying endocrine disruption, breast cancer cell biology, and reproductive physiology utilize anastrozole as a fundamental tool for aromatase enzyme inhibition studies. This compound’s mechanism involves competitive binding to the aromatase active site, preventing the conversion of androgens to estrogens in tissue culture systems. Laboratories investigating post-menopausal hormone dynamics and estrogen receptor signalling pathways find anastrozole particularly valuable for establishing baseline conditions in experimental protocols. The compound’s selectivity profile makes it ideal for researchers examining aromatase inhibitor mechanisms across various tissue models.
Biochemical Research Applications
Contemporary research applications for anastrozole span multiple disciplines within molecular endocrinology and cancer biology. Cell culture studies examining estrogen-responsive gene expression commonly employ this compound to create estrogen-depleted environments for comparative analyses. Researchers investigating metabolic syndrome and adipose tissue biology utilize anastrozole to examine the role of local estrogen production in lipid metabolism and insulin sensitivity pathways. The compound proves invaluable for studies examining bone mineralisation processes and osteoblast differentiation, where estrogen signalling plays critical regulatory roles.
Academic laboratories conducting pharmacokinetic studies often employ anastrozole as a reference compound for developing novel aromatase inhibitors with improved therapeutic indices. Research teams examining cardiovascular biology investigate how estrogen depletion affects vascular reactivity and atherosclerotic processes using anastrozole-treated experimental models. This compound also supports investigations into neuroprotective mechanisms, where researchers study estrogen’s role in cognitive function and neurodegenerative disease progression. Scientists working with selective androgen receptor modulators frequently incorporate anastrozole into experimental designs to isolate androgenic effects from estrogenic conversion products.
Technical Specifications
| Parameter | Specification |
|---|---|
| Chemical Name | 2,2′-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]bis(2-methylpropionitrile) |
| CAS Registry | 120511-73-1 |
| Molecular Formula | C₁₇H₁₉N₅ |
| Molecular Weight | 293.37 g/mol |
| Mechanism | Competitive aromatase enzyme inhibition |
| Storage Requirements | Room temperature, dry environment |
| Manufacturer | Hemi Pharma |
| Research Applications | Endocrine pathway studies, cancer biology |
Quality control parameters ensure consistent potency across research batches, with analytical verification supporting reproducible experimental outcomes. The compound demonstrates excellent stability under standard laboratory storage conditions, maintaining integrity throughout extended research protocols. Researchers should verify specific analytical certificates with their supplier to confirm batch-specific parameters for critical experiments. Integration with advanced analytical techniques like LC-MS/MS enables precise quantification in biological matrices for pharmacodynamic studies. Teams investigating peptide hormone interactions often combine anastrozole with other research compounds to examine complex endocrine feedback mechanisms.
Research Compliance Standards
This anastrozole preparation from Hemi Pharma is manufactured exclusively for in-vitro research applications and laboratory investigations. The compound is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must comply with institutional guidelines and local regulations governing research chemical handling and disposal procedures.
